Clinical and molecular epidemiology of neonatal leukemia in Brazil

References

• Bader JL, Miller RW. US cancer incidence and mortality in the first year of life. Am J Dis Child 1979;133:157–159.
   PubMedGoogle Scholar
• Bresters D, Reus AC, Veerman AJ, et al. Congenital leukaemia: the Dutch experience and review of the literature. Br J Haematol 2002;117:513–524.
   PubMed Web of Science ®Google Scholar
• Isaacs H Jr. Fetal and neonatal leukemia. J Pediatr Hematol Oncol 2003;25:348–361.
   PubMed Web of Science ®Google Scholar
• Pombo de Oliveira MS, Koifman S, Vasconcelos GM, et al.; Brazilian Collaborative Study Group of Infant Acute Leukemia. Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis 2009;42:121–125.
   PubMed Web of Science ®Google Scholar
• van der Linden MH, Creemers S, Pieters R. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med 2012;17:192–195.
   PubMed Web of Science ®Google Scholar
• Emerenciano M, Agudelo Arias DP, Coser VM, et al. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer 2006;47:549–554.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Lhermitte L, Bottcher S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012;26:1908–1975.
   PubMed Web of Science ®Google Scholar
• Shaffer LG, Tommerup N. ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel: Karger Publishers; 2005.
   Google Scholar
• Konn ZJ, Wright SL, Barber KE, et al. Fluorescence In situ hybridization (FISH) as a tool for the detection of significant chromosomal abnormalities in childhood leukaemia. Methods Mol Biol 2009;538:29–55.
   PubMedGoogle Scholar
• Emerenciano M, Meyer C, Mansur MB, et al.; Brazilian Collaborative Study Group of Infant Acute Leukemia. The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia. Br J Haematol 2013;161:224–236.
   PubMed Web of Science ®Google Scholar
• Magalhaes IQ, Splendore A, Emerenciano M, et al. GATA1 mutations in acute leukemia in children with Down syndrome. Cancer Genet Cytogenet 2006;166:112–116.
   PubMed Web of Science ®Google Scholar
• Emerenciano M, Menezes J, Vasquez ML, et al. Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia. Leuk Lymphoma 2008;49:2291–2297.
   PubMed Web of Science ®Google Scholar
• Liang DC, Shih LY, Fu JF, et al. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements. Cancer 2006;106:950–956.
   Google Scholar
• Bornholdt J, Hansen J, Steiniche T, et al. K-ras mutations in sinonasal cancers in relation to wood dust exposure. BMC Cancer 2008;8:53.
   PubMed Web of Science ®Google Scholar
• Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002;70:1555–1563
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000;95:3310–3322.
   Google Scholar
• Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007;370:240–250.
   PubMed Web of Science ®Google Scholar
• Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group—protocol ALL-99. J Clin Oncol 2010;28:1911–1918.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meir P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;35:457–481.
   Google Scholar
• Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–170.
   PubMedGoogle Scholar
• Borkhardt A, Wilda M, Fuchs U, et al. Congenital leukaemia after heavy abuse of permethrin during pregnancy. Arch Dis Child Fetal Neonatal Ed 2003;88:F436–F437.
   PubMed Web of Science ®Google Scholar
• Carroll A, Civin C, Schneider N, et al. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. Blood 1991;78: 748–752.
   PubMed Web of Science ®Google Scholar
• Chang VY, Basso G, Sakamoto KM, et al. Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia. BMC Cancer 2013;13:55.
   PubMed Web of Science ®Google Scholar
• Chantrain CF, Sauvage D, Brichard B, et al. Neonatal acute myeloid leukemia in an infant whose mother was exposed to diethylstilboestrol in utero. Pediatr Blood Cancer 2009;53:220–222.
   PubMed Web of Science ®Google Scholar
• Ergin H, Ozdemir OM, Karaca A, et al. A newborn with congenital mixed phenotype acute leukemia after in vitro fertilization. Pediatr Neonatol 2013 Apr 29. [Epub ahead of print]
   PubMedGoogle Scholar
• Ferguson EC, Talley P, Vora A. Translocation (6;17)(q23;q11.2): a novel cytogenetic abnormality in congenital acute myeloid leukemia? Cancer Genet Cytogenet 2005;163:71–73.
   PubMed Web of Science ®Google Scholar
• Frontanes A, Montalvo F, Valcarcel M. Congenital leukemia with leukemia cutis: a case report. Bol Asoc Med P R 2012;104:52–54.
   PubMedGoogle Scholar
• Prigogina EL, Fleischman EW, Puchkova GP, et al. Chromosomes in acute leukemia. Hum Genet 1979;53:5–16.
   PubMed Web of Science ®Google Scholar
• Van den Berghe H, David G, Broeckaert-Van Orshoven A, et al. A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum Genet 1979;46:173–180.
   PubMed Web of Science ®Google Scholar
• van der Linden MH, Valsecchi MG, De Lorenzo P, et al. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Blood 2009;114:3764–3768.
   PubMed Web of Science ®Google Scholar
• Wong KF, Yuen HL, Siu LL, et al. t(8;16)(p11;p13) predisposes to a transient but potentially recurring neonatal leukemia. Hum Pathol 2008;39:1702–1707.
   PubMed Web of Science ®Google Scholar
• Liang DC, Shih LY, Fu JF, et al. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements. Cancer 2006;106:950–956.
   Google Scholar
• Driessen EM, van Roon EH, Spijkers-Hagelstein JA, et al. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Haematologica 2013;98:937–944.
   PubMed Web of Science ®Google Scholar
• Carpenter E, Valverde-Garduno V, Sternberg A, et al. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol 2005;128:548–551.
   PubMed Web of Science ®Google Scholar
• Manual de normas de vacinação [Internet]. Brasília, DF: Ministério da Saúde, Fundação Nacional de Saúde; 2001 June. Available from: http://www.fasa.edu.br/images/pdf/manual_de_normas_de_vacinacao.pdf
   Google Scholar
• Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012;120:3187–3205.
   PubMed Web of Science ®Google Scholar
• Maia AT, Tussiwand R, Cazzaniga G, et al. Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood. Genes Chromosomes Cancer 2004;40:38–43.
   PubMed Web of Science ®Google Scholar
• Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; 20:5695–5707.
   PubMed Web of Science ®Google Scholar
• Ishii E, Eguchi M, Eguchi-Ishimae M, et al. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells. Int J Hematol 2002;76: 74–79.
   PubMed Web of Science ®Google Scholar
• Gilliland DG. Molecular genetics of human leukemias: new insights into therapy. Semin Hematol 2002;39:6–11.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Toki T, Okuno Y, et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet 2013;45:1293–1299.
   PubMed Web of Science ®Google Scholar
• Vyas P, Crispino JD. Molecular insights into Down syndrome-associated leukemia. Curr Opin Pediatr 2007;19:9–14.
   PubMed Web of Science ®Google Scholar
• Alford KA, Reinhard K, Garnett C, et al. Analysis of GATA1 mutations in Down syndrome trasient myeloproliferative disorder and myeloid leukemia. Blood 2011;118:2222–2238.
   PubMed Web of Science ®Google Scholar